Literature DB >> 25413138

IQ SPECT allows a significant reduction in administered dose and acquisition time for myocardial perfusion imaging: evidence from a phantom study.

Federico Caobelli1, Stefano Ren Kaiser2, James T Thackeray3, Frank M Bengel3, Matteo Chieregato2, Alberto Soffientini2, Claudio Pizzocaro2, Giordano Savelli2, Marco Galelli2, Ugo Paolo Guerra2.   

Abstract

UNLABELLED: We recently demonstrated in a clinical trial the ability of a new protocol, IQ SPECT, to acquire myocardial perfusion imaging (MPI) studies in a quarter of the time (12 s/view) of the standard protocol, with preserved diagnostic accuracy. We now aim to establish the lower limit of radioactivity that can be administered to patients and the minimum acquisition time in SPECT MPI using an IQ SPECT protocol, while preserving diagnostic accuracy.
METHODS: An anthropomorphic cardiac phantom was used to acquire clinical rest scans with a simulated in vivo distribution of (99m)Tc-tetrofosmin at full dose (740 MBq) and at doses equal to 50%, 25%, and 18%. For each dose, 2 sets of images were acquired, with and without a transmural defect (TD). Variable acquisition times were also used for each dose. We analyzed raw data and reconstructed images, including no correction and correction for attenuation (AC), for scatter (SC), or for both (ACSC). Images were evaluated qualitatively and quantitatively in order to assess left ventricle (LV) wall thickness (full width at half maximum of the medial sections), TD, and cavity contrast in the LV wall. Data were compared across different acquisition times within the same dose and across doses with the same acquisition time.
RESULTS: Images were visually scored as very-good quality except those acquired with 4 s/view or less at 100% dose and 6 s/view or less with 50%, 25%, or 18% dose, due to false-positive defects. LV wall thickness was not significantly different among all acquisitions. Cavity contrast remained unchanged within the same dose for all images and tended to be higher in AC and ACSC images. TD contrast remained unchanged within the same dose for all images. In SC and no-correction images, contrast was constant for all doses. AC images had significantly higher TD contrast values, and ACSC images showed a drop in TD contrast for a 50% dose.
CONCLUSION: IQ SPECT effectively preserved both image quality and quantitative measurements with reduced acquisition time or administered dose in a phantom study. These findings suggest that approximately one eighth of the time, compared with standard protocols with a full dose, or a lower dose at an acquisition time of 12 s/view can be applied in MPI without the loss of diagnostic accuracy.
© 2014 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Entities:  

Keywords:  99mTc-tetrofosmin SPECT/CT; IQ SPECT; coronary artery disease; low counts acquisition; myocardial perfusion imaging

Mesh:

Substances:

Year:  2014        PMID: 25413138     DOI: 10.2967/jnumed.114.143560

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  19 in total

1.  How to use cardiac IQ•SPECT routinely? An overview of tips and tricks from practical experience to the literature.

Authors:  Eric Gremillet; Denis Agostini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-04       Impact factor: 9.236

2.  Comparative analysis of full-time, half-time, and quarter-time myocardial ECG-gated SPECT quantification in normal-weight and overweight patients.

Authors:  M Lecchi; I Martinelli; O Zoccarato; C Maioli; Giovanni Lucignani; A Del Sole
Journal:  J Nucl Cardiol       Date:  2016-02-24       Impact factor: 5.952

3.  Comparative analysis of cadmium-zincum-telluride cameras dedicated to myocardial perfusion SPECT: A phantom study.

Authors:  Orazio Zoccarato; Domenico Lizio; Annarita Savi; Luca Indovina; Camilla Scabbio; Lucia Leva; Angelo Del Sole; Claudio Marcassa; Roberta Matheoud; Michela Lecchi; Marco Brambilla
Journal:  J Nucl Cardiol       Date:  2015-07-02       Impact factor: 5.952

4.  Creation and characterization of normal myocardial perfusion imaging databases using the IQ·SPECT system.

Authors:  Koichi Okuda; Kenichi Nakajima; Shinro Matsuo; Chisato Kondo; Masayoshi Sarai; Yoriko Horiguchi; Takahiro Konishi; Masahisa Onoguchi; Takeshi Shimizu; Seigo Kinuya
Journal:  J Nucl Cardiol       Date:  2017-01-03       Impact factor: 5.952

5.  New techniques, distinctive population, unique normal databases.

Authors:  James R Galt
Journal:  J Nucl Cardiol       Date:  2017-05-04       Impact factor: 5.952

6.  Contemporary Cardiac SPECT Imaging-Innovations and Best Practices: An Information Statement from the American Society of Nuclear Cardiology.

Authors:  Brian G Abbott; James A Case; Sharmila Dorbala; Andrew J Einstein; James R Galt; Robert Pagnanelli; Renée P Bullock-Palmer; Prem Soman; R Glenn Wells
Journal:  J Nucl Cardiol       Date:  2018-10       Impact factor: 5.952

7.  Differences in polar-map patterns using the novel technologies for myocardial perfusion imaging.

Authors:  Orazio Zoccarato; Claudio Marcassa; Domenico Lizio; Lucia Leva; Giovanni Lucignani; Annarita Savi; Camilla Scabbio; Roberta Matheoud; Michela Lecchi; Marco Brambilla
Journal:  J Nucl Cardiol       Date:  2016-05-27       Impact factor: 5.952

8.  Automatic evaluation of myocardial perfusion on SPECT: Need for "Normality".

Authors:  Riccardo Liga; Alessia Gimelli
Journal:  J Nucl Cardiol       Date:  2017-10-25       Impact factor: 5.952

9.  Feasibility of one-eighth time gated myocardial perfusion SPECT functional imaging using IQ-SPECT.

Authors:  Federico Caobelli; James T Thackeray; Alberto Soffientini; Frank M Bengel; Claudio Pizzocaro; Ugo Paolo Guerra
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-08-01       Impact factor: 9.236

Review 10.  New Trends in Radionuclide Myocardial Perfusion Imaging.

Authors:  Guang-Uei Hung; Yuh-Feng Wang; Hung-Yi Su; Te-Chun Hsieh; Chi-Lun Ko; Ruoh-Fang Yen
Journal:  Acta Cardiol Sin       Date:  2016-03       Impact factor: 2.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.